Russell Investments Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313M Buy
3,022,292
+144,523
+5% +$12.9M 0.27% 48
2026
Q1
$206M Sell
2,877,769
-135,903
-5% -$10.5M 0.22% 68
2025
Q4
$239M Sell
3,013,672
-227,313
-7% -$17.9M 0.26% 64
2025
Q3
$244M Buy
3,240,985
+89,696
+3% +$6.15M 0.28% 56
2025
Q2
$217M Sell
3,151,289
-301,999
-9% -$19.8M 0.28% 64
2025
Q1
$234M Buy
3,453,288
+279,508
+9% +$16.7M 0.32% 51
2024
Q4
$142M Buy
3,173,780
+1,217,730
+62% +$68.3M 0.2% 93
2024
Q3
$123M Buy
1,956,050
+160,218
+9% +$9.35M 0.18% 116
2024
Q2
$106M Sell
1,795,832
-314,270
-15% -$19.7M 0.17% 112
2024
Q1
$168M Buy
2,110,102
+82,281
+4% +$6.29M 0.27% 63
2023
Q4
$160M Sell
2,027,821
-53,553
-3% -$3.81M 0.29% 66
2023
Q3
$145M Buy
2,081,374
+47,105
+2% +$3.34M 0.29% 60
2023
Q2
$141M Buy
2,034,269
+301,310
+17% +$21.4M 0.27% 66
2023
Q1
$129M Buy
1,732,959
+108,732
+7% +$9.12M 0.25% 72
2022
Q4
$151M Buy
1,624,227
+7,502
+0.5% +$724K 0.31% 51
2022
Q3
$154M Sell
1,616,725
-51,756
-3% -$5.12M 0.34% 41
2022
Q2
$155M Buy
1,668,481
+208,815
+14% +$20.4M 0.32% 49
2022
Q1
$148M Buy
1,459,666
+121,204
+9% +$12.7M 0.26% 67
2021
Q4
$138M Sell
1,338,462
-164,321
-11% -$15.2M 0.22% 86
2021
Q3
$128M Sell
1,502,783
-211,549
-12% -$17.7M 0.22% 88
2021
Q2
$143M Buy
1,714,332
+187,338
+12% +$15.3M 0.24% 69
2021
Q1
$115M Sell
1,526,994
-71,649
-4% -$5.22M 0.2% 92
2020
Q4
$109M Sell
1,598,643
-143,083
-8% -$9.31M 0.22% 86
2020
Q3
$101M Sell
1,741,726
-67,363
-4% -$4.19M 0.22% 84
2020
Q2
$117M Buy
1,809,089
+70,843
+4% +$4.46M 0.26% 69
2020
Q1
$103M Sell
1,738,246
-306,275
-15% -$20.4M 0.27% 69
2019
Q4
$152M Buy
2,044,521
+242,167
+13% +$17M 0.28% 59
2019
Q3
$113M Sell
1,802,354
-192,236
-10% -$11.4M 0.22% 96
2019
Q2
$109M Buy
1,994,590
+138,916
+7% +$7.48M 0.2% 98
2019
Q1
$99.8M Sell
1,855,674
-326,714
-15% -$20.2M 0.18% 115
2018
Q4
$143M Buy
2,182,388
+284,728
+15% +$21.3M 0.32% 51
2018
Q3
$149M Buy
1,897,660
+211,296
+13% +$15.1M 0.28% 62
2018
Q2
$110M Sell
1,686,364
-395,625
-19% -$26.1M 0.23% 76
2018
Q1
$130M Buy
2,081,989
+840,693
+68% +$60.3M 0.22% 85
2017
Q4
$90.7M Buy
1,241,296
+445,099
+56% +$32.4M 0.15% 146
2017
Q3
$64.7M Sell
796,197
-292,570
-27% -$23.1M 0.11% 208
2017
Q2
$87.6M Sell
1,088,767
-164,029
-13% -$13M 0.16% 137
2017
Q1
$98.4M Buy
1,252,796
+8,662
+0.7% +$692K 0.18% 119
2016
Q4
$98.3M Buy
+1,244,134
New +$101M 0.19% 117

Other funds holding CVS

Russell Investments Group's CVS Position: Q2 2026 in Review

Russell Investments Group increased its CVS Health (CVS) stake by 5% in Q2 2026, buying an estimated $12.9M and bringing the position to 3,022,292 shares worth $313M. The position accounts for 0.27% of the portfolio, ranked #48.

Russell Investments Group first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Russell Investments Group held 3,022,292 shares of CVS Health worth $313M as of Q2 2026.
  • Russell Investments Group bought 144,523 CVS Health shares in Q2 2026, an estimated $12.9M.
  • CVS Health made up 0.27% of Russell Investments Group's portfolio in Q2 2026, its #48 holding.
  • Russell Investments Group first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.